Cytokinetics says Phase 3 ACACIA — HCM data show aficamten boosts exercise performance in non — obstructive HCM
Additional ACACIA-HCM trial analyses were presented at the HFSA Annual Scientific Meeting 2026, extending evidence for aficamten in non-obstructive HCM. New exercise-performance analyses showed broader improvement versus placebo, aligning with better patient-reported health status and supportive biomarker trends. A res